{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T16:37:12Z","timestamp":1769877432248,"version":"3.49.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progr\u00e8s en Urologie"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.purol.2016.10.005","type":"journal-article","created":{"date-parts":[[2016,12,7]],"date-time":"2016-12-07T10:16:07Z","timestamp":1481105767000},"page":"253-260","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["\u00c9valuation prospective de l\u2019impact des anticholinergiques sur la s\u00e9cheresse buccale et oculaire chez 35\u00a0patients atteints de scl\u00e9rose en plaque avec hyperactivit\u00e9 v\u00e9sicale neurog\u00e8ne"],"prefix":"10.1016","volume":"27","author":[{"given":"L.","family":"Weglinski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Manceau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Thomas-Pohl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Le Breton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Amarenco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6A\u00a0Suppl.","key":"10.1016\/j.purol.2016.10.005_bib0105","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/S0090-4295(97)00599-2","article-title":"Clinical efficacy and safety of tolterodine in the treatment of overactive bladder: a pooled analysis","volume":"50","author":"Appell","year":"1997","journal-title":"Urology"},{"issue":"5","key":"10.1016\/j.purol.2016.10.005_bib0110","first-page":"718","article-title":"Dry mouth with conventional and controlled-release oxybutynin in urinary incontinence. The Ditropan XL Study Group","volume":"95","author":"Versi","year":"2000","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.purol.2016.10.005_bib0115","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1080\/10790268.2004.11753751","article-title":"Efficacy and safety of tolterodine in people with neurogenic detrusor overactivity","volume":"27","author":"Ethans","year":"2004","journal-title":"J Spinal Cord Med"},{"issue":"2","key":"10.1016\/j.purol.2016.10.005_bib0120","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s11255-004-4703-7","article-title":"Comparison of dry mouth in women treated with extended-release formulations of oxybutynin or tolterodine for overactive bladder","volume":"37","author":"Armstrong","year":"2005","journal-title":"Int Urol Nephrol"},{"issue":"1","key":"10.1016\/j.purol.2016.10.005_bib0125","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.eururo.2006.03.016","article-title":"Propiverine compared to oxybutynin in neurogenic detrusor overactivity\u00a0\u2013\u00a0results of a randomized, double-blind, multicenter clinical study","volume":"51","author":"St\u00f6hrer","year":"2007","journal-title":"Eur Urol"},{"issue":"6","key":"10.1016\/j.purol.2016.10.005_bib0130","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1111\/j.1464-410X.2008.08093.x","article-title":"Propiverine vs oxybutynin for treating neurogenic detrusor overactivity in children and adolescents: results of a multicentre observational cohort study","volume":"103","author":"Madersbacher","year":"2009","journal-title":"BJU Int"},{"issue":"5","key":"10.1016\/j.purol.2016.10.005_bib0135","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.eururo.2012.02.036","article-title":"Anticholinergic drugs for adult neurogenic detrusor overactivity: a systematic review and meta-analysis","volume":"62","author":"Madhuvrata","year":"2012","journal-title":"Eur Urol"},{"issue":"5","key":"10.1016\/j.purol.2016.10.005_bib0140","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.phrs.2007.02.002","article-title":"A standardised mini pig model for in vivo investigations of anticholinergic effects on bladder function and salivation","volume":"55","author":"Scheepe","year":"2007","journal-title":"Pharmacol Res"},{"issue":"6","key":"10.1016\/j.purol.2016.10.005_bib0145","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1007\/BF00868392","article-title":"Subclinical autonomic disturbances in multiple sclerosis","volume":"242","author":"Linden","year":"1995","journal-title":"J Neurol"},{"issue":"17","key":"10.1016\/j.purol.2016.10.005_bib0150","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/j.purol.2013.06.010","article-title":"[Autonomic nervous system alteration in multiple sclerosis patients with urinary symptoms. Clinical, urodynamic and cardiovascular study]","volume":"23","author":"Amarenco","year":"2013","journal-title":"Prog Urol"},{"issue":"2","key":"10.1016\/j.purol.2016.10.005_bib0155","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1212\/WNL.43.2.455-a","article-title":"MS and Sj\u00f6gren's syndrome","volume":"43","author":"Alexander","year":"1993","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.purol.2016.10.005_bib0160","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1212\/WNL.57.8.1359","article-title":"The prevalence of Sj\u00f6gren syndrome in patients with primary progressive multiple sclerosis","volume":"57","author":"de Seze","year":"2001","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.purol.2016.10.005_bib0165","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1177\/1352458514564490","article-title":"A systematic review of the incidence and prevalence of autoimmune disease in multiple sclerosis","volume":"21","author":"Marrie","year":"2015","journal-title":"Mult Scler"},{"issue":"12","key":"10.1016\/j.purol.2016.10.005_bib0170","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1177\/0091270006292126","article-title":"The Anticholinergic Drug Scale as a measure of drug-related anticholinergic burden: associations with serum anticholinergic activity","volume":"46","author":"Carnahan","year":"2006","journal-title":"J Clin Pharmacol"},{"issue":"1","key":"10.1016\/j.purol.2016.10.005_bib0175","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ijrobp.2009.04.021","article-title":"Xerostomia after treatment for oral and oropharyngeal cancer using the University of Washington saliva domain and a Xerostomia-Related Quality-of-Life Scale","volume":"77","author":"Rogers","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.purol.2016.10.005_bib0180","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1067\/moe.2001.111551","article-title":"Development of a Visual Analogue Scale questionnaire for subjective assessment of salivary dysfunction","volume":"91","author":"Pai","year":"2001","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endodontol"},{"issue":"5","key":"10.1016\/j.purol.2016.10.005_bib0185","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1001\/archopht.118.5.615","article-title":"Reliability and validity of the Ocular Surface Disease Index","volume":"118","author":"Schiffman","year":"2000","journal-title":"Arch Ophthalmol"},{"issue":"14","key":"10.1016\/j.purol.2016.10.005_bib0190","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1001\/archinternmed.2009.229","article-title":"Drugs with anticholinergic properties, cognitive decline, and dementia in an elderly general population: the 3-city study","volume":"169","author":"Carri\u00e8re","year":"2009","journal-title":"Arch Intern Med"},{"issue":"7539","key":"10.1016\/j.purol.2016.10.005_bib0195","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1136\/bmj.38740.439664.DE","article-title":"Non-degenerative mild cognitive impairment in elderly people and use of anticholinergic drugs: longitudinal cohort study","volume":"332","author":"Ancelin","year":"2006","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.purol.2016.10.005_bib0100","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1365-2125.2004.02232.x","article-title":"Drugs with anticholinergic properties and cognitive performance in the elderly: results from the PAQUID Study","volume":"59","author":"Lechevallier-Michel","year":"2005","journal-title":"Br J Clin Pharmacol"}],"container-title":["Progr\u00e8s en Urologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1166708716306613?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1166708716306613?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T06:28:29Z","timestamp":1761114509000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1166708716306613"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S1166708716306613"],"URL":"https:\/\/doi.org\/10.1016\/j.purol.2016.10.005","relation":{},"ISSN":["1166-7087"],"issn-type":[{"value":"1166-7087","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u00c9valuation prospective de l\u2019impact des anticholinergiques sur la s\u00e9cheresse buccale et oculaire chez 35\u00a0patients atteints de scl\u00e9rose en plaque avec hyperactivit\u00e9 v\u00e9sicale neurog\u00e8ne","name":"articletitle","label":"Article Title"},{"value":"Progr\u00e8s en Urologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.purol.2016.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}